Shopping Cart
Remove All
Your shopping cart is currently empty
D-3263 is an agonist of transient receptor potential melatonin member 8 (TRPM8) with potential antitumor activity.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $1,670 | 1-2 weeks | 1-2 weeks | |
| 50 mg | $2,180 | 1-2 weeks | 1-2 weeks | |
| 100 mg | $2,800 | 1-2 weeks | 1-2 weeks |
| Description | D-3263 is an agonist of transient receptor potential melatonin member 8 (TRPM8) with potential antitumor activity. |
| In vitro | D-3263 triggers calcium flux and induces cell death in TRPM8-expressing cells in vitro. |
| In vivo | D-3263 alone (50 or 100 mg / kg / d) or in combination with finasteride (10 mg / kg / d) can lead to decreased prostate hyperplasia in rats, with evidence of dose response. The highest dose of TRPM8 agonist D-3263 combined with finasteride caused lower prostate weight than the highest dose of D-3263 or finasteride alone, indicating a potential additive effect. |
| Molecular Weight | 373.49 |
| Formula | C21H31N3O3 |
| Cas No. | 947257-66-1 |
| Smiles | C(=O)(N1C=2C(N(CCN)C1=O)=CC(OC)=CC2)[C@H]3[C@H](C(C)C)CC[C@@H](C)C3 |
| Relative Density. | 1.137 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.